Breaking News

North American Artificial Disc Replacement Market Set to More Than Double

By GlobalData | May 17, 2017

Sector expected to grow 12.2 percent annually through 2023.

The North American artificial disc replacement (ADR) market, which covers Canada, Mexico, and the United States, is set to more than double from $274.6 million in 2016 to around $614.5 million by 2023, representing a compound annual growth rate of 12.2 percent, according to research and consulting firm GlobalData.
The company’s latest report states that key drivers of the market include the growing prevalence of degenerative spinal conditions due to the aging population and advantages over traditional spinal fusion procedures, including motion preservation and reduced likelihood of reoperation.
“Currently, cervical disc replacement represents the most common spinal non-fusion procedure performed globally. Due to a growing body of evidence supporting clinical efficacy and improving reimbursement scenarios, the adoption of cervical ADR systems is expected to continue increasing through the forecast period," explained Jennifer Ryan, healthcare analyst for GlobalData. "Additionally, approval for use of cervical systems in multi-level indication will also serve to drive growing adoption, as patients and physicians seek to avoid the motion-restricting effects of multi-level fusion.”
Although cervical ADR is expected to drive growth of the global spinal non-fusion market, lumbar ADR systems have not yet achieved significant market adoption. A scarcity of clinical evidence demonstrating superiority over spinal fusion, coupled with a more complicated implantation procedure, has contributed to slow adoption of lumbar ADR systems.
The leading players in the global ADR market are large multinationals with an established presence in the orthopedic and spine markets. DePuy Synthes and Medtronic plc are the chief players in the space, followed by Globus Medical and Zimmer Biomet Inc.

“Beyond these major players, the current market includes small- to mid-sized companies, many of which are focused on novel spine or spinal nonfusion devices. As the ADR market continues to attract new entrants, GlobalData expects to see an increase in mergers and acquisitions activity as the large players seek to expand their current product offerings through smaller players with innovative technologies,” Ryan continued.
About 4,000 of the world’s largest companies, including more than 70 percent of FTSE 100 and 60 percent of Fortune 100 companies, make timely and better business decisions thanks to GlobalData’s unique data, expert analysis and innovative solutions, all in one platform. GlobalData’s mission is to help our clients decode the future to be more successful and innovative across a range of industries, including the healthcare, consumer, retail, financial, technology and professional services sectors.

Related News:

Related Markets:

  • Loading Orthopedic Devices with Biologics and Pharmaceuticals

    Loading Orthopedic Devices with Biologics and Pharmaceuticals

    Dr. Kevin Nelson, Founder and CSO, TissueGen Inc.||May 19, 2017
    Fiber technology enables the delivery of the therapeutic components via a biodegradable platform that can be implanted.

  • Looking Beneath the Surface

    Looking Beneath the Surface

    Sam Brusco, Associate Editor||May 19, 2017
    Surface treatments seek to improve orthopedic device usability, longevity, and bone integration.

  • Going to Extremes

    Going to Extremes

    Michael Barbella, Managing Editor||May 19, 2017
    The innovation and market value found in extremity solutions is prompting a change of heart among major orthopedic firms.